Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Role of Non-coding RNAs in Oncology
Frank J. Slack, Arul M. Chinnaiyan
Cell (2019) Vol. 179, Iss. 5, pp. 1033-1055
Open Access | Times Cited: 1246

Showing 1-25 of 1246 citing articles:

Noncoding RNA therapeutics — challenges and potential solutions
Melanie Winkle, Sherien M. El‐Daly, Muller Fabbri, et al.
Nature Reviews Drug Discovery (2021) Vol. 20, Iss. 8, pp. 629-651
Open Access | Times Cited: 1123
Cancer Immune Evasion Through Loss of MHC Class I Antigen Presentation
Karthik Dhatchinamoorthy, Jeff D. Colbert, Kenneth L. Rock
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 673
Long noncoding RNAs in cancer metastasis
Siyuan Liu, Ha X. Dang, Daniel A. Lim, et al.
Nature reviews. Cancer (2021) Vol. 21, Iss. 7, pp. 446-460
Open Access | Times Cited: 501
Antisense Oligonucleotides: An Emerging Area in Drug Discovery and Development
Karishma Dhuri, Clara Bechtold, Elias Quijano, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 6, pp. 2004-2004
Open Access | Times Cited: 383
Mechanisms of Metabolic Reprogramming in Cancer Cells Supporting Enhanced Growth and Proliferation
Chelsea Schiliro, Bonnie L. Firestein
Cells (2021) Vol. 10, Iss. 5, pp. 1056-1056
Open Access | Times Cited: 367
Targeting mutant p53 for cancer therapy: direct and indirect strategies
Jiahao Hu, Jiasheng Cao, Win Topatana, et al.
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 351
NLRP3 inflammasome in endothelial dysfunction
Baochen Bai, Yanyan Yang, Qi Wang, et al.
Cell Death and Disease (2020) Vol. 11, Iss. 9
Open Access | Times Cited: 347
Non-coding RNAs in disease: from mechanisms to therapeutics
Kinga Németh, Recep Bayraktar, Manuela Ferracin, et al.
Nature Reviews Genetics (2023) Vol. 25, Iss. 3, pp. 211-232
Closed Access | Times Cited: 327
Supermeres are functional extracellular nanoparticles replete with disease biomarkers and therapeutic targets
Qin Zhang, Dennis K. Jeppesen, James N. Higginbotham, et al.
Nature Cell Biology (2021) Vol. 23, Iss. 12, pp. 1240-1254
Open Access | Times Cited: 292
CRISPR in cancer biology and therapy
Alyna Katti, Bianca J. Diaz, Christina M. Caragine, et al.
Nature reviews. Cancer (2022) Vol. 22, Iss. 5, pp. 259-279
Open Access | Times Cited: 288
Sex differences in cancer mechanisms
Joshua B. Rubin, J. S. Lagas, Lauren Broestl, et al.
Biology of Sex Differences (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 274
Review on circular RNAs and new insights into their roles in cancer
Xiaozhu Tang, Hongyan Ren, Mengjie Guo, et al.
Computational and Structural Biotechnology Journal (2021) Vol. 19, pp. 910-928
Open Access | Times Cited: 269
Meta-hallmarks of aging and cancer
Carlos López‐Otín, Federico Pietrocola, David Roiz‐Valle, et al.
Cell Metabolism (2023) Vol. 35, Iss. 1, pp. 12-35
Open Access | Times Cited: 263
Integrating CRISPR-Cas12a with a DNA circuit as a generic sensing platform for amplified detection of microRNA
Shuang Peng, Zhen Tan, Siyu Chen, et al.
Chemical Science (2020) Vol. 11, Iss. 28, pp. 7362-7368
Open Access | Times Cited: 216
The role of hypoxia‐inducible factor 1 in tumor immune evasion
You Li, Wenda Wu, Xu Wang, et al.
Medicinal Research Reviews (2020) Vol. 41, Iss. 3, pp. 1622-1643
Closed Access | Times Cited: 210
Enterotoxigenic Bacteroides fragilis Promotes Intestinal Inflammation and Malignancy by Inhibiting Exosome-Packaged miR-149-3p
Yingying Cao, Zhenhua Wang, Yuqing Yan, et al.
Gastroenterology (2021) Vol. 161, Iss. 5, pp. 1552-1566.e12
Closed Access | Times Cited: 196
Modern epigenetics methods in biological research
Yuanyuan Li
Methods (2020) Vol. 187, pp. 104-113
Open Access | Times Cited: 192
Epigenetics in hepatocellular carcinoma
Ganji Purnachandra Nagaraju, Begum Dariya, Prameswari Kasa, et al.
Seminars in Cancer Biology (2021) Vol. 86, pp. 622-632
Closed Access | Times Cited: 188
Biological Function of Long Non-coding RNA (LncRNA) Xist
Wenlun Wang, Lu Min, Xinyuan Qiu, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 180
Integrated Analysis of lncRNA–Mediated ceRNA Network in Lung Adenocarcinoma
Xianxian Wu, Zhilin Sui, Hongdian Zhang, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 173
Challenges identifying efficacious miRNA therapeutics for cancer
Meirav Segal, Frank J. Slack
Expert Opinion on Drug Discovery (2020) Vol. 15, Iss. 9, pp. 987-991
Open Access | Times Cited: 171
Non-coding RNAs in GI cancers: from cancer hallmarks to clinical utility
Mihnea P. Dragomir, Scott Kopetz, Jaffer A. Ajani, et al.
Gut (2020) Vol. 69, Iss. 4, pp. 748-763
Closed Access | Times Cited: 169
New insights into the interplay between long non‐coding RNAs and RNA‐binding proteins in cancer
Ziting Yao, Yuan‐Han Yang, Miaomiao Sun, et al.
Cancer Communications (2022) Vol. 42, Iss. 2, pp. 117-140
Open Access | Times Cited: 168
Exosomal miRNAs in tumor microenvironment
Shiming Tan, Longzheng Xia, Pin Yi, et al.
Journal of Experimental & Clinical Cancer Research (2020) Vol. 39, Iss. 1
Open Access | Times Cited: 157
Long non-coding RNAs in the doxorubicin resistance of cancer cells
Saeed Ashrafizaveh, Milad Ashrafizadeh, Ali Zarrabi, et al.
Cancer Letters (2021) Vol. 508, pp. 104-114
Open Access | Times Cited: 152
Page 1 - Next Page

Scroll to top